Stock ABMT ADVANCED BIOMEDICAL TECHNOLOGIES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

All News Advanced BioMedical Technologies, Inc.

Equities

ABMT

US00752M1018

Delayed OTC Markets
Other stock markets
 14:25:03 2024-05-15 EDT 		5-day change 1st Jan Change
0.0006 USD 0.00% Intraday chart for Advanced BioMedical Technologies, Inc. 0.00% -98.48%
2021 Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021 CI
2021 Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2021 CI

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Advanced Biomedical Technologies : Attorney Letter with Respect to Annual Report FYE 10/30/2021 and Quarterly Report FPE 1/31/2022
PU
Advanced Biomedical Technologies : Quarterly Report for the period ended January 31, 2022
PU
Advanced Biomedical Technologies : Quarterly Report for the period ended January 31, 2022
PU
Advanced Biomedical Technologies : Annual Report for the year ending October 31, 2021
PU
Advanced Biomedical Technologies : Notification of Late Filing
PU
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2021
CI
Advanced Biomedical Technologies : Quarterly Report (SEC Filing - 10-Q)
PU
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2021
CI
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Full Year Ended October 31, 2020
CI
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Third Quarter Ended July 31, 2020
CI
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q/A)
AQ
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the Second Quarter Ended April 30, 2020
CI
ADVANCED BIOMEDICAL TECHNOLOGIES : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)
AQ
Advanced Biomedical Technologies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2020
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABMT Stock
  4. News Advanced BioMedical Technologies, Inc.
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW